<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37663631</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Polio outbreaks in Cameroon following the COVID-19 pandemic.</ArticleTitle><Pagination><StartPage>90</StartPage><MedlinePgn>90</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">90</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.2023.45.90.35332</ELocationID><Abstract><AbstractText>Polio is an infectious and disabling life-threatening disease caused by the poliovirus. This disease is prevented through vaccination. Though this viral infection has been eliminated in most parts of the world, a few countries are still endemic to wild poliovirus. In 2020, the World Health Organization (WHO) African Region, including Cameroon, was certified free of wild poliovirus. Some countries recurrently report circulating vaccine-derived poliovirus cases (cVDPV) despite recorded achievements. Also, the risk of importing poliovirus from endemic settings remains, particularly in the context of coronavirus disease (COVID-19). This study aimed to assess the state of polio in Cameroon and identify the situation during COVID-19. A data review was conducted from February to March 2023. Data on polio cases and vaccination coverage per region of Cameroon were reviewed from 2014 to 2022. Data were analyzed with Microsoft Excel, and the results were presented as proportions. The last wild poliovirus was reported in Cameroon in 2014, and the country benefitted from a response. No case of poliovirus was detected in the country from 2015 to 2018. After that, an increasing number of type two cVDPV were reported across 50% of the country's regions from 2019 to 2022. The outbreaks benefitted from responses with various oral polio vaccines, including the type two novel oral polio vaccine (nOPV-2). Though wild polioviruses have been eliminated in most countries, including Cameroon, cVDPV remains a significant problem. There is an urgent need to strengthen disease surveillance and vaccination to prevent cVDPV-2 in this country, particularly in the COVID-19 context.</AbstractText><CopyrightInformation>Copyright: Andreas Ateke Njoh et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Njoh</LastName><ForeName>Andreas Ateke</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Expanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Global Health and Bioethics, Euclid University, Bangui, Central African Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Josue Kedakse</LastName><ForeName>Tchokfe Shalom Ndoula</ForeName><Initials>TSN</Initials><AffiliationInfo><Affiliation>Expanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eric Mboke</LastName><ForeName>Ekoum</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Expanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nembot</LastName><ForeName>Raoul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Expanded Program on Immunization, Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Collins</LastName><ForeName>Lele Youmssi Parfait</ForeName><Initials>LYP</Initials><AffiliationInfo><Affiliation>World Health Organization, Cameroon Country Office, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amani</LastName><ForeName>Adidja</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachire</LastName><ForeName>Hassan Ben</ForeName><Initials>HB</Initials><AffiliationInfo><Affiliation>Ministry of Public Health, Yaoundé, Cameroon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gulma</LastName><ForeName>Kabiru Abubakar</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>School of Global Health and Bioethics, Euclid University, Bangui, Central African Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Kiev</LastName><ForeName>Laurent Cleenewerck</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>School of Global Health and Bioethics, Euclid University, Bangui, Central African Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002163" MajorTopicYN="N" Type="Geographic">Cameroon</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001766" MajorTopicYN="N">Blindness</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cameroon</Keyword><Keyword MajorTopicYN="N">Polio</Keyword><Keyword MajorTopicYN="N">circulating vaccine-derived poliovirus</Keyword><Keyword MajorTopicYN="N">outbreak</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>4</Day><Hour>5</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37663631</ArticleId><ArticleId IdType="pmc">PMC10474802</ArticleId><ArticleId IdType="doi">10.11604/pamj.2023.45.90.35332</ArticleId><ArticleId IdType="pii">PAMJ-45-90</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention (CDC) What is Polio? 2021. Updated January 9, 2023 Accessed 19th February, 2022.</Citation></Reference><Reference><Citation>Wolbert JG, Higginbotham K. StatPearls [Internet] Treasure, Island (FL): StatPearls Publishing; 2023. Jan, Poliomyelitis. 2022, Accessed 19th February 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32644370</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard RS. Poliomyelitis and the postpolio syndrome. BMJ. 2005;330(7503):1314–1318.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC558211</ArticleId><ArticleId IdType="pubmed">15933355</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative (GPEI) OPV: Oral poliovirus vaccine. Accessed 19th February 2022.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative (GPEI) IPV: Inactivated poliovirus vaccine. Accessed 19th February 2022.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative (GPEI) Circulating vaccine-derived poliovirus. Accessed 19th February 2022.</Citation></Reference><Reference><Citation>National Institute for Biological Standards and Control (NIBSC) New polio vaccines. Accessed 19th February 2022.</Citation></Reference><Reference><Citation>&gt;The U.S. Government and Global Polio Efforts. 2022. Accessed 6th March, 2022.</Citation></Reference><Reference><Citation>World Health Organization Africa Malawi declares polio outbreak. 2022. Accessed 3rd May 2022.</Citation></Reference><Reference><Citation>Chinele J, Prabhu M. 2022. Wild polio returns to Africa: How the GPEI is helping stop an outbreak from becoming an inferno. Accessed 30th March, 2023.</Citation></Reference><Reference><Citation>World Health Organization . 2013. Wild poliovirus in Cameroon: 2013 - Cameroon. Accessed 4th June, 2023.</Citation></Reference><Reference><Citation>World Health Organization Africa's wild polio-free status to be determined in August. 2020. Accessed 3rd May 2022.</Citation></Reference><Reference><Citation>Chelo D, Nguefack F, Enyama D, Nansseu R, Feudjo Tefoueyet G, Mbassi Awa HD, et al. Impact and projections of the COVID-19 epidemic on attendance and routine vaccinations at a pediatric referral hospital in Cameroon. Arch Pediatr. 2021 Aug;28(6):441–450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188383</ArticleId><ArticleId IdType="pubmed">34140219</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations High Commissioner for Refugees (UNHCR) UNHCR Cameroon MCO Factsheet - January 2022. 2022. Accessed 30th March, 2023.</Citation></Reference><Reference><Citation>World Health Organization Africa eradicates wild poliovirus. 2020. Accessed 6th March, 2022.</Citation></Reference><Reference><Citation>World Health Organization COVID-19 widens routine immunization gaps in Africa. 2021. Accessed 3rd May 2022.</Citation></Reference><Reference><Citation>Ho LL, Gurung S, Mirza I, Nicolas HD, Steulet C, Burman AL, et al. Impact of the SARS-CoV-2 pandemic on vaccine-preventable disease campaigns. Int J Infect Dis. 2022;119:201–209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8985404</ArticleId><ArticleId IdType="pubmed">35398300</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC) Fast Facts on Global Immunization. 2023. Accessed 5th June, 2023.</Citation></Reference><Reference><Citation>Taniuchi M, Famulare M, Zaman K, Uddin MJ, Upfill-Brown AM, Ahmed T, et al. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study. Lancet Infect Dis. 2017;17(10):1069–1079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5610141</ArticleId><ArticleId IdType="pubmed">28693854</ArticleId></ArticleIdList></Reference><Reference><Citation>Amani A, Djossaya D, Njoh AA, Fouda AAB, Ndoula S, Abba-kabir HM, et al. The first 30 days of COVID-19 vaccination in Cameroon: achievements, challenges, and lessons learned. Pan African Medical Journal. 2022;41:201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9146659</ArticleId><ArticleId IdType="pubmed">35685114</ArticleId></ArticleIdList></Reference><Reference><Citation>Saidu Y, Vouking M, Njoh AA, Bachire HB, Tonga C, Mofor R, et al. The effect of the ongoing civil strife on key immunisation outcomes in the North West and South West regions of Cameroon. Confl Health. 2021 Feb 10;15(1):8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7877013</ArticleId><ArticleId IdType="pubmed">33568157</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Children's Fund (UNICEF) 2021. Special focus session on the Global Overview Status of Polio Eradication: Presentation and statements. Accessed 3rd May, 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>